Comparison of the Changes in Corneal Endothelial Cells after Pars Plana and Anterior Chamber Ahmed Valve Implant
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Seo, Ji Won | - |
dc.contributor.author | Lee, Jong Yeon | - |
dc.contributor.author | Nam, Dong Heun | - |
dc.contributor.author | Lee, Dae Yeong | - |
dc.date.available | 2020-02-28T14:45:21Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2015 | - |
dc.identifier.issn | 2090-004X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/11899 | - |
dc.description.abstract | Purpose. To compare the changes in corneal endothelial cells after pars plana Ahmed glaucoma valve (AGV) implantation with those after the anterior chamber AGV implantation for refractory glaucoma. Methods. The medical records of 18 eyes with pars plana implantation of AGV (ppAGV) were reviewed retrospectively and were compared with 18 eyes with the anterior chamber AGV (acAGV) implant. The preoperative and postoperative endothelial cells, intraocular pressure (IOP), and postoperative complications during the follow-up in both groups were compared. Results. The average follow-up was 18 months. The postoperative endothelial cells in the ppAGV and acAGV groups were 2044 +/- 303 and 1904 +/- 324, respectively (P = 0.25). The average percentage decrease in the endothelial cells in the ppAGV and acAGV groups at 18 months was 12.5% and 18.4%, respectively, and showed significant difference between the 2 groups (P = 0.01). No difference in IOP control and the number of postoperative glaucoma medications was observed between the 2 groups. Conclusions. Endothelial cell damage in the ppAGV group for refractory glaucoma appeared to be lower than that in the acAGV group. Therefore, pars plana implantation of AGV may be preferred as it may have lower level of endothelial cell damage while maintaining similar level of IOP control. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | HINDAWI LTD | - |
dc.relation.isPartOf | JOURNAL OF OPHTHALMOLOGY | - |
dc.subject | GLAUCOMA VALVE | - |
dc.subject | CLINICAL-EXPERIENCE | - |
dc.subject | TUBE-SHUNT | - |
dc.subject | VITRECTOMY | - |
dc.subject | PLACEMENT | - |
dc.subject | OUTCOMES | - |
dc.subject | DENSITY | - |
dc.title | Comparison of the Changes in Corneal Endothelial Cells after Pars Plana and Anterior Chamber Ahmed Valve Implant | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000349253600001 | - |
dc.identifier.doi | 10.1155/2015/486832 | - |
dc.identifier.bibliographicCitation | JOURNAL OF OPHTHALMOLOGY | - |
dc.identifier.scopusid | 2-s2.0-84937135789 | - |
dc.citation.title | JOURNAL OF OPHTHALMOLOGY | - |
dc.contributor.affiliatedAuthor | Seo, Ji Won | - |
dc.contributor.affiliatedAuthor | Lee, Jong Yeon | - |
dc.contributor.affiliatedAuthor | Nam, Dong Heun | - |
dc.contributor.affiliatedAuthor | Lee, Dae Yeong | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | GLAUCOMA VALVE | - |
dc.subject.keywordPlus | CLINICAL-EXPERIENCE | - |
dc.subject.keywordPlus | TUBE-SHUNT | - |
dc.subject.keywordPlus | VITRECTOMY | - |
dc.subject.keywordPlus | PLACEMENT | - |
dc.subject.keywordPlus | OUTCOMES | - |
dc.subject.keywordPlus | DENSITY | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.relation.journalResearchArea | Ophthalmology | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.relation.journalWebOfScienceCategory | Ophthalmology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.